Antitumor Effect of -derived Outer Membrane Vesicles on Neuroblastoma and

Overview

Journal Acta Biochim Biophys Sin (Shanghai)

Specialties Biochemistry
Biophysics

Date 2022 Sep 23

PMID 36148954

Authors

Liming Jin

Zhaoxia Zhang

Xiaojun Tan

Zhaoying Wang

Bo Tang

Zhang Wang

Mujie Li

Tao Mi

Lianju Shen

Chunlan Long

Guanghui Wei

Dawei He

Affiliations

Soon will be listed here.

Abstract

Bacterial outer membrane vesicles (OMVs) are spherical microbubbles that contain biological content and are produced by gram-negative bacteria. The use of OMVs as adjuvants for cancer immunotherapy or as drug carriers for targeted therapies has attracted the interest of many scholars. However, it is unclear whether OMVs can exert direct antitumor effects and whether OMVs can inhibit pediatric tumors. Here, we explore the potential of -derived OMVs to directly suppress neuroblastoma. Our results demonstrate the antitumor effects of OMVs and , and no serious adverse reactions were observed. OMV uptake into the cytoplasm and nucleus directly decreases cell stemness, DNA damage, apoptosis and cell cycle arrest, which may be the mechanisms by which OMVs suppress tumors. Our results demonstrate the potential of bacterial OMVs to be used as antitumor adjuvant therapies, increasing the number of candidates for the development of cancer therapies in the future. More relevant studies are urgently needed to demonstrate the efficacy and safety of OMVs.

Citing Articles

Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells.

Abdessalem M, Adham S Oncol Res. 2024; 33(1):27-44.

PMID: 39735681 PMC: 11671623. DOI: 10.32604/or.2024.056955.

Study on the biosafety and targeting efficiency of Escherichia coli outer membrane vesicles in breast tumor.

Ma G, Chen Z, Wang L, Chang X, Fang L, Bai J J Mol Histol. 2024; 56(1):5.

PMID: 39601965 DOI: 10.1007/s10735-024-10296-0.

The emerging role of bacterial extracellular vesicles in human cancers.

Liang A, Korani L, Yeung C, Tey S, Yam J J Extracell Vesicles. 2024; 13(10):e12521.

PMID: 39377479 PMC: 11460218. DOI: 10.1002/jev2.12521.

Bacterial outer membrane vesicles in the fight against cancer.

Meng Y, Kong C, Ma Y, Sun J, Zhang G Chin Med J (Engl). 2024; .

PMID: 39118214 PMC: 11407815. DOI: 10.1097/CM9.0000000000003234.

An Overview on the Physiopathology of the Blood-Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery.

Susa F, Arpicco S, Pirri C, Limongi T Pharmaceutics. 2024; 16(7).

PMID: 39065547 PMC: 11279990. DOI: 10.3390/pharmaceutics16070849.

References

Maya-Mendoza A, Moudry P, Merchut-Maya J, Lee M, Strauss R, Bartek J . High speed of fork progression induces DNA replication stress and genomic instability. Nature. 2018; 559(7713):279-284. DOI: 10.1038/s41586-018-0261-5. View

Rickman D, Schulte J, Eilers M . The Expanding World of N-MYC-Driven Tumors. Cancer Discov. 2018; 8(2):150-163. DOI: 10.1158/2159-8290.CD-17-0273. View

Chen Q, Bai H, Wu W, Huang G, Li Y, Wu M . Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention. Nano Lett. 2019; 20(1):11-21. DOI: 10.1021/acs.nanolett.9b02182. View

Helmink B, Khan M, Hermann A, Gopalakrishnan V, Wargo J . The microbiome, cancer, and cancer therapy. Nat Med. 2019; 25(3):377-388. DOI: 10.1038/s41591-019-0377-7. View

Gujrati V, Kim S, Kim S, Min J, Choy H, Kim S . Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano. 2014; 8(2):1525-37. DOI: 10.1021/nn405724x. View

Sui X, Liang X, Chen L, Guo C, Han W, Pan H . Bacterial xenophagy and its possible role in cancer: A potential antimicrobial strategy for cancer prevention and treatment. Autophagy. 2016; 13(2):237-247. PMC: 5324843. DOI: 10.1080/15548627.2016.1252890. View

Seoane J, Le H, Massague J . Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 2002; 419(6908):729-34. DOI: 10.1038/nature01119. View

King B, Boccalatte F, Moran-Crusio K, Wolf E, Wang J, Kayembe C . The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells. Nat Immunol. 2016; 17(11):1312-1321. PMC: 5117833. DOI: 10.1038/ni.3559. View

Chen Q, Huang G, Wu W, Wang J, Hu J, Mao J . A Hybrid Eukaryotic-Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination. Adv Mater. 2020; 32(16):e1908185. DOI: 10.1002/adma.201908185. View

10.

Apte R, Chen D, Ferrara N . VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019; 176(6):1248-1264. PMC: 6410740. DOI: 10.1016/j.cell.2019.01.021. View

11.

Novak D, Huser L, Elton J, Umansky V, Altevogt P, Utikal J . SOX2 in development and cancer biology. Semin Cancer Biol. 2019; 67(Pt 1):74-82. DOI: 10.1016/j.semcancer.2019.08.007. View

12.

Lytle N, Barber A, Reya T . Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018; 18(11):669-680. PMC: 8388042. DOI: 10.1038/s41568-018-0056-x. View

13.

Li Y, Zhao R, Cheng K, Zhang K, Wang Y, Zhang Y . Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy Immune Activation and Checkpoint Inhibition. ACS Nano. 2020; 14(12):16698-16711. DOI: 10.1021/acsnano.0c03776. View

14.

Kim O, Park H, Dinh N, Choi S, Lee J, Kim J . Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nat Commun. 2017; 8(1):626. PMC: 5606984. DOI: 10.1038/s41467-017-00729-8. View

15.

Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M . Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009; 460(7259):1132-5. PMC: 2917235. DOI: 10.1038/nature08235. View

16.

Deng C, Zhang P, Harper J, Elledge S, Leder P . Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995; 82(4):675-84. DOI: 10.1016/0092-8674(95)90039-x. View

17.

Molenaar J, Domingo-Fernandez R, Ebus M, Lindner S, Koster J, Drabek K . LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet. 2012; 44(11):1199-206. DOI: 10.1038/ng.2436. View

18.

Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L . Proapoptotic BID is an ATM effector in the DNA-damage response. Cell. 2005; 122(4):593-603. DOI: 10.1016/j.cell.2005.06.014. View

19.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

20.

Kastenhuber E, Lowe S . Putting p53 in Context. Cell. 2017; 170(6):1062-1078. PMC: 5743327. DOI: 10.1016/j.cell.2017.08.028. View